Deletion of spontaneous rat liver allograft acceptance by donor irradiation.

PubWeight™: 1.00‹?› | Rank: Top 15%

🔗 View Article (PMID 7645034)

Published in Transplantation on August 15, 1995

Authors

J Sun1, G W McCaughan, N D Gallagher, A G Sheil, G A Bishop

Author Affiliations

1: Department of Transplantation Surgery, University of Sydney, New South Wales, Australia.

Articles citing this

The lost chord: microchimerism and allograft survival. Immunol Today (1996) 2.81

Immunomodulation for intestinal transplantation by allograft irradiation, adjunct donor bone marrow infusion, or both. Transplantation (2000) 1.53

The site of primary T cell activation is a determinant of the balance between intrahepatic tolerance and immunity. J Clin Invest (2004) 1.53

Dendritic cells and immune regulation in the liver. Gut (2003) 1.19

Functional changes of dendritic cells derived from allogeneic partial liver graft undergoing acute rejection in rats. World J Gastroenterol (2003) 0.94

Increased apoptosis of immunoreactive host cells and augmented donor leukocyte chimerism, not sustained inhibition of B7 molecule expression are associated with prolonged cardiac allograft survival in mice preconditioned with immature donor dendritic cells plus anti-CD40L mAb. Transplantation (1999) 0.92

The fas and fas ligand pathways in liver allograft tolerance. Clin Exp Immunol (1999) 0.89

Hematopoietic cell transplantation for tolerance induction: animal models to clinical trials. Transplantation (2009) 0.89

Donor pretreatment with Flt-3 ligand augments antidonor cytotoxic T lymphocyte, natural killer, and lymphokine-activated killer cell activities within liver allografts and alters the pattern of intragraft apoptotic activity. Transplantation (1998) 0.81

Chronic rejection. A general overview of histopathology and pathophysiology with emphasis on liver, heart and intestinal allografts. Ann Transplant (1997) 0.79

Relative contribution of direct and indirect allorecognition in developing tolerance after liver transplantation. Liver Transpl (2008) 0.78

DAP12 deficiency in liver allografts results in enhanced donor DC migration, augmented effector T cell responses and abrogation of transplant tolerance. Am J Transplant (2014) 0.78

Inhibition of cytotoxic alloreactivity by human allogeneic mononuclear cells: evidence for veto function of CD2+ cells. Immunology (1998) 0.77

The role of graft-resident Kupffer cells and lymphocytes of donor type during the time course after liver transplantation--a clinico-pathological study. Virchows Arch (2003) 0.77

Pathology of Chronic Rejection: An Overview of Common Findings and Observations About Pathogenic Mechanisms and Possible Prevention. Graft (Georget Tex) (1998) 0.76

Liver transplant tolerance and its application to the clinic: can we exploit the high dose effect? Clin Dev Immunol (2013) 0.76

The CD8 T-cell response during tolerance induction in liver transplantation. Clin Transl Immunology (2016) 0.75

Immunotoxin Against a Donor MHC Class II Molecule Induces Indefinite Survival of Murine Kidney Allografts. Am J Transplant (2016) 0.75

Articles by these authors

CpG motifs in bacterial DNA trigger direct B-cell activation. Nature (1995) 12.24

Collaborative United Kingdom-Australasian study of cancer in patients treated with immunosuppressive drugs. Br Med J (1979) 5.58

Periacinar stellate shaped cells in rat pancreas: identification, isolation, and culture. Gut (1998) 3.77

Pancreatic stellate cells are activated by proinflammatory cytokines: implications for pancreatic fibrogenesis. Gut (1999) 3.36

A simple, rapid method for the purification of poly A+ RNA. Biotechniques (1988) 3.22

Community treatment of end-stage renal failure by dialysis and renal transplantation from cadaver donors. Lancet (1969) 2.53

Asian Pacific Association for the Study of the Liver consensus statements on the diagnosis, management and treatment of hepatitis C virus infection. J Gastroenterol Hepatol (2007) 2.35

Activation of pancreatic stellate cells in human and experimental pancreatic fibrosis. Am J Pathol (1999) 2.12

Progressive liver injury in chronic hepatitis C infection correlates with increased intrahepatic expression of Th1-associated cytokines. Hepatology (1996) 2.01

Terlipressin therapy for moderate-to-severe hyponatraemia in patients with liver failure. Intern Med J (2013) 2.00

Systematic review of role of polymerase chain reaction in defining infectiousness among people infected with hepatitis C virus. BMJ (1997) 1.92

Real-time reverse transcriptase-polymerase chain reaction (RT-PCR) for measurement of cytokine and growth factor mRNA expression with fluorogenic probes or SYBR Green I. Immunol Cell Biol (2001) 1.85

Fibroblast activation protein: a cell surface dipeptidyl peptidase and gelatinase expressed by stellate cells at the tissue remodelling interface in human cirrhosis. Hepatology (1999) 1.84

Controlled clinical trial of antilymphocyte globulin in patients with renal allografts from cadaver donors. Lancet (1971) 1.82

The CH series of murine B cell lymphomas: neoplastic analogues of Ly-1+ normal B cells. Immunol Rev (1986) 1.81

Recruitment of CD40 and tumor necrosis factor receptor-associated factors 2 and 3 to membrane microdomains during CD40 signaling. J Biol Chem (2000) 1.70

High-dose/activation-associated tolerance: a mechanism for allograft tolerance. Transplantation (1997) 1.65

A short course of methylprednisolone immunosuppression inhibits both rejection and spontaneous acceptance of rat liver allografts. Transplantation (2001) 1.61

Increased expression of HLA-DR antigens on renal tubular cells in renal transplants: relevance to the rejection response. Lancet (1984) 1.57

Does alcohol directly stimulate pancreatic fibrogenesis? Studies with rat pancreatic stellate cells. Gastroenterology (2000) 1.55

Malignancy in a 19-year experience of adult celiac disease. Dig Dis Sci (1979) 1.54

CD26: a multifunctional integral membrane and secreted protein of activated lymphocytes. Scand J Immunol (2001) 1.53

The effect of heterologous immune serum on canine renal homografts. Transplantation (1966) 1.52

Cord blood mononuclear cell cytokine responses in relation to maternal house dust mite allergen exposure. Clin Exp Allergy (2002) 1.51

Varicella-zoster virus Fc receptor gE glycoprotein: serine/threonine and tyrosine phosphorylation of monomeric and dimeric forms. J Virol (1997) 1.50

Differential signaling and tumor necrosis factor receptor-associated factor (TRAF) degradation mediated by CD40 and the Epstein-Barr virus oncoprotein latent membrane protein 1 (LMP1). J Exp Med (2001) 1.48

Antigen-specific primary activation of CD8+ T cells within the liver. J Immunol (2001) 1.47

Induced differentiation of a transformed clone of Ly-1+ B cells by clonal T cells and antigen. Proc Natl Acad Sci U S A (1986) 1.46

Physiological changes during liver transplantation. Anaesth Intensive Care (1989) 1.43

Saphenous-vein arteriovenous fistula in regular dialysis treatment. N Engl J Med (1969) 1.42

Multiple endoscopies in a Sydney blood donor found positive for hepatitis B and C antibodies. Med J Aust (1996) 1.40

Retrieval of organs for transplantation: experience of the Australian National Liver Transplantation Unit. Med J Aust (1996) 1.39

Effect of liver transplantation on islet allografts: up-regulation of Fas ligand and apoptosis of T lymphocytes are associated with islet graft tolerance. Transplantation (2001) 1.38

Cloning, expression and chromosomal localization of a novel human dipeptidyl peptidase (DPP) IV homolog, DPP8. Eur J Biochem (2000) 1.32

Relationship between expression of herpes simplex virus glycoproteins and susceptibility of target cells to human natural killer activity. J Exp Med (1983) 1.27

Membrane-bound CD154, but not CD40-specific antibody, mediates NF-kappaB-independent IL-6 production in B cells. Eur J Immunol (1999) 1.25

Characterization of the human homolog of the rat MRC OX-2 membrane glycoprotein. Immunogenetics (1987) 1.24

Automobile emissions are statistically gamma distributed. Environ Sci Technol (1994) 1.24

Long-term survival with tumor regression in androgen-induced liver tumors. Cancer (1985) 1.23

Intrahepatic hepatitis C RNA levels do not correlate with degree of liver injury in patients with chronic hepatitis C. Hepatology (1996) 1.19

Fas-mediated apoptosis in human prostatic carcinoma cell lines. Cancer Res (1997) 1.19

The gene for MRC OX-2 membrane glycoprotein is localized on human chromosome 3. Immunogenetics (1987) 1.18

False detection of negative-strand hepatitis C virus RNA. Lancet (1994) 1.18

Cancer and survival after cadaveric donor renal transplantation. Transplant Proc (1979) 1.18

Increases in intrahepatic CD68 positive cells, MAC387 positive cells, and proinflammatory cytokines (particularly interleukin 18) in chronic hepatitis C infection. Gut (2000) 1.18

Characterization of CD40 signaling determinants regulating nuclear factor-kappa B activation in B lymphocytes. J Immunol (1997) 1.17

Specificity of human natural killer cells in limiting dilution culture for determinants of herpes simplex virus type 1 glycoproteins. J Virol (1986) 1.16

Cutting edge: contrasting roles of TNF receptor-associated factor 2 (TRAF2) and TRAF3 in CD40-activated B lymphocyte differentiation. J Immunol (1999) 1.15

Different CD40-mediated signaling events require distinct CD40 structural features. J Immunol (1996) 1.15

Transmission of hepatitis C virus to infants of human immunodeficiency virus-negative intravenous drug-using mothers: rate of infection and assessment of risk factors for transmission. J Viral Hepat (1997) 1.14

Cancer development in patients progressing to dialysis and renal transplantation. Transplant Proc (1985) 1.14

On-road vehicle emissions: regulations, costs, and benefits. Science (1995) 1.11

Human natural killer cell recognition of herpes simplex virus type 1 glycoproteins: specificity analysis with the use of monoclonal antibodies and antigenic variants. J Immunol (1984) 1.11

Molecular pathogenesis of liver disease: an approach to hepatic inflammation, cirrhosis and liver transplant tolerance. Immunol Rev (2000) 1.11

Identification of novel molecules and pathogenic pathways in primary biliary cirrhosis: cDNA array analysis of intrahepatic differential gene expression. Gut (2001) 1.10

Inflammatory pseudotumor of the liver causing biliary obstruction. Treatment by biliary stenting with 5-year follow-up. J Clin Gastroenterol (1991) 1.09

Cancer in renal allograft recipients in Australia and New Zealand. Transplant Proc (1977) 1.09

Oxygen binding constants for human hemoglobin tetramers. Biochemistry (1987) 1.09

Two highly conserved glutamic acid residues in the predicted beta propeller domain of dipeptidyl peptidase IV are required for its enzyme activity. FEBS Lett (1999) 1.09

The EBV transforming protein, latent membrane protein 1, mimics and cooperates with CD40 signaling in B lymphocytes. J Immunol (1999) 1.08

Evidence that portal tract microvascular destruction precedes bile duct loss in human liver allograft rejection. Transplantation (1993) 1.08

Immunologic relationships between skin and kidney homografts in dogs on immunosuppressive therapy. Transplantation (1966) 1.07

Genomic organization, exact localization, and tissue expression of the human CD26 (dipeptidyl peptidase IV) gene. Immunogenetics (1994) 1.06

Characterization of the roles of TNF receptor-associated factor 6 in CD40-mediated B lymphocyte effector functions. J Immunol (2000) 1.05

Cancer following successful cadaveric donor renal transplantation. Transplant Proc (1981) 1.05

Cytokine profiles in spontaneously regressing basal cell carcinomas. Br J Dermatol (2000) 1.05

Medium spiny neuron projection from the rat striatum: an intracellular horseradish peroxidase study. Brain Res (1980) 1.04

Combination low-dose hepatitis B immune globulin and lamivudine therapy provides effective prophylaxis against posttransplantation hepatitis B. Liver Transpl (2000) 1.04

Antilymphocyte globulin in patients with renal allografts from cadaveric donors. Late results of a controlled trail. Lancet (1973) 1.04

Role of interferon in human natural killer activity against target cells infected with HSV-1. J Immunol (1983) 1.04

Liver transplantation for HCV-associated liver cirrhosis: predictors of outcomes in a population with significant genotype 3 and 4 distribution. Liver Transpl (2003) 1.03

Reversal of renal failure by revascularisation of kidneys with thrombosed renal arteries. Lancet (1973) 1.03

Iatrogenic incarceration of umbilical hernia in cirrhotic patients with ascites. Am J Gastroenterol (1995) 1.02

Increased intrahepatic messenger RNA expression of interleukins 2, 6, and 8 in human cirrhosis. Gastroenterology (1994) 1.02

Neuronal/lymphoid membrane glycoprotein MRC OX-2 is a member of the immunoglobulin superfamily with a light-chain-like structure. Biochem Soc Symp (1986) 1.02

Immunopathology of renal allograft rejection analyzed with monoclonal antibodies to mononuclear cell markers. Kidney Int (1986) 1.01

Physiological and anatomical studies of the interactions between Purkinje cells and basket cells in the cat's cerebellar cortex: evidence for a unitary relationship. J Neurosci (1989) 1.01

Deaths from occlusive arterial disease in renal allograft recipients. Br Med J (1974) 1.01

Sentinel skin allograft-a reliable marker for monitoring of composite tissue transplant rejection. Transplant Proc (2009) 1.00

T helper 1 cytokine mRNA is increased in spontaneously regressing primary melanomas. J Invest Dermatol (1997) 0.99

CD40 ligation results in protein kinase C-independent activation of ERK and JNK in resting murine splenic B cells. J Immunol (1996) 0.99

A controlled clinical trial of machine perfusion of cadaveric donor renal allografts. Lancet (1975) 0.98

Sequential increases in the intrahepatic expression of epidermal growth factor, basic fibroblast growth factor, and transforming growth factor beta in a bile duct ligated rat model of cirrhosis. Hepatology (1997) 0.98

Aortic occlusion and vascular isolation allowing avascular hepatic resection. Arch Surg (1990) 0.98

Morphological and physiological properties of neostriatal neurons: an intracellular horseradish peroxidase study in the rat. Neuroscience (1982) 0.97

Bone loss after liver transplantation. Hepatology (1991) 0.97

Evidence that apoptosis of activated T cells occurs in spontaneous tolerance of liver allografts and is blocked by manipulations which break tolerance. Transplantation (1999) 0.97